4//SEC Filing
Ocera Therapeutics, Inc. 4
Accession 0001104659-13-091987
CIK 0001274644operating
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:32 PM ET
Size
15.5 KB
Accession
0001104659-13-091987
Insider Transaction Report
Form 4
ROUSSEAU FRANCK
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2013-08-13+226,000→ 226,000 totalExercise: $7.38Exp: 2023-08-13→ Common Stock (226,000 underlying)
Footnotes (3)
- [F1]Option to purchase Common Stock granted by the Issuer pursuant to the Issuer's Second Amended and Restated 2011 Stock Option and Incentive Plan (the "Plan"), qualified under Rule 16b-3(d).
- [F2]The Issuer granted the option on August 13, 2013, subject to stockholder approval of the Plan, which was obtained on December 19, 2013.
- [F3]The option shall vest and become exercisable with respect to 25% of the shares covered by the grant on August 13, 2014, subject to the Reporting Person's continued service to the Issuer through such date, with the balance to vest in equal monthly installments over the next succeeding three year period, subject to the Reporting Person's continued service to the Issuer through each such date.
Documents
Issuer
Ocera Therapeutics, Inc.
CIK 0001274644
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001274644
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 4:32 PM ET
- Size
- 15.5 KB